Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Hemab Therapeutics Holdings, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
hemab.comAI Executive Summary
AI-powered analysis of 8-K filing content
Keli Walbert was elected as a Class I director of Hemab Therapeutics Holdings, Inc. on September 24, 2026, and appointed to the Audit Committee, reflecting the company's effort to strengthen its governance structure and board oversight capabilities.
Key Takeaways
Keli Walbert joins the Board of Directors as a Class I director with a term expiring at the 2027 annual stockholder meeting
Ms. Walbert has been appointed to the Audit Committee, indicating the company is prioritizing financial oversight and governance
2 more takeaways
Filing Overview
What This Means
Hemab Therapeutics Holdings, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.